1. Home
  2. XNCR vs AG Comparison

XNCR vs AG Comparison

Compare XNCR & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • AG
  • Stock Information
  • Founded
  • XNCR 1997
  • AG 1979
  • Country
  • XNCR United States
  • AG Canada
  • Employees
  • XNCR N/A
  • AG N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • AG Precious Metals
  • Sector
  • XNCR Health Care
  • AG Basic Materials
  • Exchange
  • XNCR Nasdaq
  • AG Nasdaq
  • Market Cap
  • XNCR 1.7B
  • AG 1.9B
  • IPO Year
  • XNCR 2013
  • AG N/A
  • Fundamental
  • Price
  • XNCR $24.20
  • AG $5.46
  • Analyst Decision
  • XNCR Strong Buy
  • AG Buy
  • Analyst Count
  • XNCR 9
  • AG 2
  • Target Price
  • XNCR $36.33
  • AG $7.50
  • AVG Volume (30 Days)
  • XNCR 850.2K
  • AG 9.0M
  • Earning Date
  • XNCR 11-06-2024
  • AG 02-20-2025
  • Dividend Yield
  • XNCR N/A
  • AG 0.33%
  • EPS Growth
  • XNCR N/A
  • AG N/A
  • EPS
  • XNCR N/A
  • AG N/A
  • Revenue
  • XNCR $85,164,000.00
  • AG $525,212,999.00
  • Revenue This Year
  • XNCR N/A
  • AG N/A
  • Revenue Next Year
  • XNCR $89.22
  • AG $28.06
  • P/E Ratio
  • XNCR N/A
  • AG N/A
  • Revenue Growth
  • XNCR N/A
  • AG N/A
  • 52 Week Low
  • XNCR $15.31
  • AG $4.17
  • 52 Week High
  • XNCR $27.24
  • AG $8.44
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 44.92
  • AG 34.11
  • Support Level
  • XNCR $22.74
  • AG $5.42
  • Resistance Level
  • XNCR $25.54
  • AG $6.78
  • Average True Range (ATR)
  • XNCR 1.17
  • AG 0.27
  • MACD
  • XNCR -0.33
  • AG -0.08
  • Stochastic Oscillator
  • XNCR 22.00
  • AG 2.45

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines, in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine and the La Encantada Silver Mine.

Share on Social Networks: